Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials

Figure 3

Odds ratio of (a): cardiac death (b): myocardial infarction and (c): target vessel revascularization associated with everolimus-eluting stent versus paclitaxel-eluting stent.

(a)

(b)

(c)